De Boer MJ - Search Results

1

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, Wijns W, Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer MJ, Claeys MJ, Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T, Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J, Karamfiloff KK, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D, Najafov R, Nicolini FA, Noč M, Ostojic M, Pereira H, Radovanovic D, Sabaté M, Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P; European Association for Percutaneous Cardiovascular Interventions. Kristensen SD, et al. Among authors: de boer mj. Eur Heart J. 2014 Aug 1;35(29):1957-70. doi: 10.1093/eurheartj/eht529. Epub 2014 Jan 12. Eur Heart J. 2014. PMID: 24419804 Free article.

2

High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.

de Boer SP, Barnes EH, Westerhout CM, Simes RJ, Granger CB, Kastrati A, Widimsky P, de Boer MJ, Zijlstra F, Boersma E. de Boer SP, et al. Among authors: de boer mj. Am Heart J. 2011 Mar;161(3):500-507.e1. doi: 10.1016/j.ahj.2010.11.022. Am Heart J. 2011. PMID: 21392604

3

Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

De Luca G, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Suryapranata H. De Luca G, et al. Among authors: de boer mj. Eur Heart J. 2005 Apr;26(7):662-6. doi: 10.1093/eurheartj/ehi110. Epub 2005 Jan 28. Eur Heart J. 2005. PMID: 15681574

4

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

De Luca G, van 't Hof AW, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, Zijlstra F, Suryapranata H. De Luca G, et al. Among authors: de boer mj. Eur Heart J. 2004 Jun;25(12):1009-13. doi: 10.1016/j.ehj.2004.03.021. Eur Heart J. 2004. PMID: 15191770

5

Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).

van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Gans RO, de Boer MJ, Zijlstra F; GIPS Investigators. van der Horst IC, et al. Among authors: de boer mj. Am Heart J. 2005 Apr;149(4):585-91. doi: 10.1016/j.ahj.2004.09.010. Am Heart J. 2005. PMID: 15990738 Clinical Trial.

6

Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction.

De Luca G, Maas AC, Suryapranata H, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, van 't Hof AW. De Luca G, et al. Among authors: de boer mj. Am Heart J. 2005 Dec;150(6):1248-54. doi: 10.1016/j.ahj.2005.01.056. Am Heart J. 2005. PMID: 16338267

7

Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.

Zijlstra F, de Boer MJ, Beukema WP, Liem AL, Reiffers S, Huysmans D, Hoorntje JC, Suryapranata H, Simoons ML. Zijlstra F, et al. Among authors: de boer mj. Eur Heart J. 1996 Mar;17(3):382-7. doi: 10.1093/oxfordjournals.eurheartj.a014869. Eur Heart J. 1996. PMID: 8737211 Clinical Trial.

8

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.

de Boer MJ, Reiber JH, Suryapranata H, van den Brand MJ, Hoorntje JC, Zijlstra F. de Boer MJ, et al. Eur Heart J. 1995 Oct;16(10):1347-55. doi: 10.1093/oxfordjournals.eurheartj.a060741. Eur Heart J. 1995. PMID: 8746902 Clinical Trial.

9

Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.

van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. van 't Hof AW, et al. Among authors: de boer mj. Eur Heart J. 1998 Jan;19(1):118-23. doi: 10.1053/euhj.1997.0746. Eur Heart J. 1998. PMID: 9503184

10

Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, van't Hof AW; Zwolle Myocardial Infarction Study Group. Nienhuis MB, et al. Among authors: de boer mj. Am Heart J. 2008 Apr;155(4):673-9. doi: 10.1016/j.ahj.2007.11.004. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page